Gerald Maguire to Humans
This is a "connection" page, showing publications Gerald Maguire has written about Humans.
Connection Strength
0.149
-
Stahl SM, Sy S, Maguire GA. How and when to treat the most common adverse effects of antipsychotics: Expert review from research to clinical practice. Acta Psychiatr Scand. 2021 02; 143(2):172-180.
Score: 0.036
-
Maguire GA, LaSalle L, Hoffmeyer D, Nelson M, Lochhead JD, Davis K, Burris A, Yaruss JS. Ecopipam as a pharmacologic treatment of stuttering. Ann Clin Psychiatry. 2019 08; 31(3):164-168.
Score: 0.032
-
Sung CT, Choi F, Wang SH, Jacobs N, Maguire GA. Nonantipsychotic therapies for delusions of parasitosis. Ital J Dermatol Venerol. 2021 02; 156(1):95-96.
Score: 0.031
-
Charoensook J, Maguire GA. A case series on the effectiveness of lurasidone in patients with stuttering. Ann Clin Psychiatry. 2017 Aug; 29(3):191-194.
Score: 0.028
-
Grover D, Tom M, Maguire G, Stahl S. Polypharmacy- Purpose, Benefits and Limitations. Curr Med Chem. 2022; 29(35):5606-5614.
Score: 0.010
-
Reddy HM, Poole JS, Maguire GA, Stahl SM. New Medications for Neuropsychiatric Disorders. Psychiatr Clin North Am. 2020 06; 43(2):399-413.
Score: 0.009
-
Gottschalk LA, Bechtel RJ, Maguire GA, Katz ML, Levinson DM, Harrington DE, Nakamura K, Franklin DL. Computer detection of cognitive impairment and associated neuropsychiatric dimensions from the content analysis of verbal samples. Am J Drug Alcohol Abuse. 2002 Nov; 28(4):653-70.
Score: 0.003